Centric Wealth Management’s Agile Therapeutics AGRX Stock Holding History

Centric Wealth Management’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5	Closed	-$5K	–	174
2021 Q4	$5K	Hold	5	–	–	﹤0.01%	153
2021 Q3	$10K	Hold	5	–	–	﹤0.01%	152
2021 Q2	$13K	Hold	5	–	–	﹤0.01%	149
2021 Q1	$21K	Hold	5	–	–	0.01%	209
2020 Q4	$29K	Hold	5	–	–	0.01%	195
2020 Q3	$11K	Hold	5	–	–	0.01%	115
2020 Q2	$28K	Hold	5	–	–	0.01%	140
2020 Q1	$11K	Buy	+5	New	+$28.7K	0.01%	115
2019 Q4	–	Sell	-5	Closed	-$11K	–	136
2019 Q3	$11K	Hold	5	–	–	0.01%	115
2019 Q2	$15K	Hold	5	–	–	0.01%	110
2019 Q1	$15K	Hold	5	–	–	0.01%	96
2018 Q4	$6K	Buy	+5	New	+$7.66K	0.01%	111

Other funds holding AGRX

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return